Jeantet advises Sartorius Stedim Biotech on the acquisition of Novasep’s chromatography process equipment division

 

Paris, 6 January 2021 – Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, today announced it has entered into an agreement to acquire the chromatography process equipment division of Novasep. The parties agreed not to disclose the purchase price until the necessary regulatory approvals have been obtained.

Novasep’s division expects to generate sales revenue of approximately 37 million euros in 2020 at double-digit profit margins and employs approximately 100 people, the majority of whom work at its Pompey site in northern France and some in the USA, China and India. The proposed transaction is subject to antitrust approvals and the information and consultation of Novasep’s works council and is expected to close during the first half of 2021.

Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. The Group has been annually growing by double digits on average and has been regularly expanding its portfolio by acquisitions of complementary technologies. In 2019, the company employed approx. 6,200 people, and earned sales revenue of 1,440.6 million euros.

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. Novasep’s unique offering includes process development services, purification equipment and turnkey processes, contract manufacturing services and complex active molecules to serve pharmaceutical, biopharmaceutical, fine chemical, food and functional ingredients, as well as fermentation and chemical commodities industries.

Sartorius Stedim Biotech was advised by Jeantet with a team lead by Karl Hepp de Sevelinges (partner, Corporate/M&A), including Michael Samol (counsel, Corporate/M&A), Robert d’Orglandes (associate, Corporate/M&A), Laetitia Ternisien (counsel, Employment) and Gabriel di Chiara (counsel, Tax).

The firm Milbank LLP has worked closely with Jeantet, notably with Michael Bernhardt (partner, Corporate/M&A) and Alexander Rinne (partner, Antitrust), as well as the firm GvW Graf von Westphalen for Chinese law aspects.

Novasep was advised by White & Case LLP with a team lead by François Leloup (partner, Corporate/M&A), including Delphin Boucher (counsel, Corporate/M&A), Alexandre Jaurett (partner, Employment) and Orion Berg (counsel, Regulatory). Teams in the New-York and Washington offices have been involved on US law aspects and a team in the Shanghai office has been involved on Chinese law aspects.

Our last press releases

Jeantet advises 2CRSi in the context of its share capital increase by way of private placement with a public offering aimed at retail investors (via the Primarybid platform) for a total amount of €12 million

Paris, March 20, 2024 – Jeantet advised 2CRSi in the context of its share capital increase by way of private placement to qualified investors with a public offering aimed at retail investors via the PrimaryBid platform on Euronext Growth Paris, for a total amount of €12 million. The total demand for the transaction amounted to […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advises ENERTIME in the context of its share capital increase without preferential subscription rights by way of a public offering and with a priority period for its existing shareholders on Euronext Growth Paris

Paris, March 8, 2024 – Jeantet advised Enertime in the context of its share capital increase without preferential subscription rights of the shareholders by way of a public offering and with a priority period, on an irreducible and reducible basis, for its shareholders and of a global placement on Euronext Growth Paris, for a total […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advised JUNGBUNZLAUER group in the context of the acquisition of ALLIANCE GUMS & INDUSTRIES from ROQUETTE group

Paris, 1 March 2024 – Jeantet advised Jungbunzlauer group on the acquisition of Alliance Gums & Industries from Roquette Ventures, part of the Roquette group. On February 29, 2024, Jungbunzlauer group completed the acquisition of Alliance Gums & Industries from Roquette Ventures, part of the Roquette group. Alliance Gums & Industries is an expert blending […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised MOBILITY TRADER HOLDING in the context of the sale of CARIZY to COFIDIS GROUP

Paris, 2 February 2024 – Jeantet advised Mobility Trader Holding GmbH, the parent company of the heycar group (Berlin, Germany), held by the Volkswagen, Allianz and Renault groups on the sale of Carizy SAS to the Cofidis group. On January 31, 2024, Mobility Trader Holding GmbH, the parent company of the heycar group (Berlin Germany), […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises SWEN CAPITAL PARTNERS on its investment in LANGA INTERNATIONAL in connection with a 85 million euros capital increase

Paris, 29 January 2024 – JEANTET advises SWEN Capital Partners on its investment in LANGA INTERNATIONAL, an independent developer and producer of renewable electricity in France and internationally. JEANTET assists SWEN Capital Partners (via SWIFT 2 – SWEN Impact Fund for Transition 2) in this second round of funding, alongside Bpifrance and RGREEN INVEST, historical […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advises HEEX TECHNOLOGIES on its EUR 6 million fundraising round

Paris, 19 January 2024 – Founded in 2019 by Bruno Mendes Da Silva and Arnaud de La Fortelle, Heex Technologies is a French start-up which is committed to support and accelerate the development of artificial intelligence, while reducing its environmental impact, with the “Smart Data” technology it has developed. After proving itself in the mobility […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised EB-SIM in the context of the acquisition of three wind parks from Volkswind, a subsidiary of the Swiss energy company Axpo

Paris, 3 January 2024 – Jeantet advised EB Sustainable Investment Management GmbH on the acquisition of a portfolio of three operating wind farms with a total nominal capacity of 72 MW from Volkswind GmbH, a subsidiary of the Swiss energy company Axpo. On December 15, 2023, Volkswind GmbH, German subsidiary of the Swiss energy company […]

Paris | CORPORATE – M&A – PRIVATE EQUITY | ENERGY

+

Jeantet advises SII Goes On and Société pour l’Informatique Industrielle (SII) in the context of the proposed simplified tender offer for SII shares to be launched by SII Goes On

Paris, 15 December 2023 – Jeantet advises Société pour l’Informatique Industrielle (SII), a leading international group in engineering, technology consulting and digital services, listed on Euronext Paris, with a sales turnover of one billion euros during its last financial year, and SII Goes On, a company created for the purposes of the transaction and controlled […]

Paris | CAPITAL MARKETS AND STOCK EXCHANGE LAW

+

Jeantet advises Quandela in its EUR 50 million fundraising

Jeantet advises Quandela, an European leader in quantum photonics, co-founded by Niccolo Somachi, Valérian Giesz and Pascale Senellart-Mardon, in its EUR 50 million fundraising. At the end of 2022, Quandela became the first player in the European Union, and one of the few worldwide, to make quantum computers accessible via the cloud, with the acquisition […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised Equinox Industries in the acquisition of Clear Channel France

Paris, 7 November 2023 – Jeantet advised Equinox Industries, industrial French holding, in the acquisition of Clear Channel France, the second largest advertising operator in France. After several months of exclusive negotiations and an information and consultation process that culminated in a positive opinion from the works council of Clear Channel France (CCF), Equinox Industries, […]

| CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet advised Komax in the acquisition of Alcava, Lintech, Malintech and Tulintech

Paris, 18 October 2023 – Jeantet advised Komax in the acquisition of Alcava SAS including Lintech in France, Malintech in Morrocco and Tulintech in Tunisia. Komax is a listed Swiss company specialized in the industrial equipment sector, and market and technology leader in automated cable handling solutions. The cross-border transaction involved the acquisition of Alcava […]

Paris | CORPORATE – M&A – PRIVATE EQUITY

+

Jeantet takes on the criminal business world with the arrival of Philippe Bouchez El Ghozi

Paris, Thursday September 14, 2023, Jeantet is delighted to announce the arrival of Philippe Bouchez El Ghozi and his team as partners to strengthen the commercial litigation practice, and in particular the criminal business law, compliance and internal investigations practice. With this arrival, Jeantet now has 35 partners and intends to continue its growth. This […]

+